Consortium Drug Abuse Rehabilitation Program

Consortium Drug Abuse Rehabilitation Program (Philadelphia, PA) is a SAMHSA Behavioral Health Treatment Services Locator-registered facility. The specific care levels offered by Consortium Drug Abuse Rehabilitation Program should be confirmed directly with the admissions team. Evaluation of this facility against current clinical standards should encompass ASAM 4e framework alignment, MAT policy, and payer-specific network status.

Care levels at Consortium Drug Abuse Rehabilitation Program

Care-level specifics for Consortium Drug Abuse Rehabilitation Program are not well-documented in the public SAMHSA record; a direct conversation with the admissions team is the reliable way to confirm what the facility actually provides. ASAM Criteria 4e level-of-care matching requires clinical assessment across six dimensions (withdrawal potential, biomedical conditions, emotional/behavioral/cognitive conditions, readiness, relapse risk, recovery environment). The alignment of Consortium Drug Abuse Rehabilitation Program's offerings to any specific patient's clinical profile should be determined by an independent ASAM-aligned assessment prior to admission.

Insurance and payment

Payment and insurance specifics for Consortium Drug Abuse Rehabilitation Program are not fully documented in the SAMHSA registry — a direct admissions conversation is the reliable way to confirm what forms of payment are accepted and at what network-contract level. The operational prerequisite for admission is written documentation of: (a) network contract status; (b) prior authorization; (c) cost-sharing structure; (d) medical-necessity criteria applied. Absence of any of these four increases the probability of post-admission financial disagreement.

Before you call

Operational admission checklist for Consortium Drug Abuse Rehabilitation Program: (a) clinical assessment with documented ASAM 4e level-of-care recommendation; (b) insurance benefits verification in writing; (c) MAT policy documentation; (d) accreditation and licensure verification; (e) confirmed prior authorization for specific level of care. Each should be obtained in written form prior to admission. If the clinical situation involves opioid use disorder, confirm explicitly whether Consortium Drug Abuse Rehabilitation Program offers medication-assisted treatment — buprenorphine, methadone, or naltrexone. Programs that do not are operating outside the current standard of care.